von Figura K, Steckel F, Hasilik A
Proc Natl Acad Sci U S A. 1983 Oct;80(19):6066-70. doi: 10.1073/pnas.80.19.6066.
Arylsulfatase A polypeptides were examined in cultured fibroblasts from a patient with juvenile metachromatic leukodystrophy and three patients with the adult form of the disease, with the aid of metabolic labeling and immunoprecipitation. The mutant cells were severely deficient in the arylsulfatase polypeptides. The apparent rate of synthesis, however, as estimated from the secretion of polypeptides or activity by cells incubated in the presence of 10 mM NH4Cl was 20-50% of control. In the absence of NH4Cl, the mutant enzyme was rapidly degraded upon transport into lysosomes. In the presence of inhibitors of thiol proteinases arylsulfatase A polypeptides were partially protected from degradation, and the catalytic activity of arylsulfatase A was increased. In addition, the treatment partially corrected the capacity of the cells to degrade cerebroside sulfates. Inhibitors of thiol proteinases may be of therapeutic value in variants of metachromatic leukodystrophy, in which an unstable arylsulfatase A is synthesized.
借助代谢标记和免疫沉淀技术,对一名患有青少年型异染性脑白质营养不良的患者以及三名患有成人型该疾病的患者的培养成纤维细胞中的芳基硫酸酯酶A多肽进行了检测。突变细胞中的芳基硫酸酯酶多肽严重缺乏。然而,根据在10 mM氯化铵存在下培养的细胞分泌的多肽或活性估计,其表观合成速率为对照的20 - 50%。在没有氯化铵的情况下,突变酶在转运到溶酶体后会迅速降解。在巯基蛋白酶抑制剂存在的情况下,芳基硫酸酯酶A多肽受到部分保护而不被降解,并且芳基硫酸酯酶A的催化活性增加。此外,该处理部分纠正了细胞降解脑硫脂的能力。巯基蛋白酶抑制剂可能对合成不稳定芳基硫酸酯酶A的异染性脑白质营养不良变体具有治疗价值。